The Patent Finder

Impax Laboratories, Inc.

Also on record
Records under this name other than the patents Impax Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.

Showing 1 to 9 of 9 · Back to Impax Laboratories, Inc.

PatentTitleStatus Expires Confidence
US 8,007,827Pharmaceutical Dosage Forms Having Immediate Release And/Or Controlled Release Properties
Lapsed on the fee record
Ended Aug 30, 2023 · Medium confidence
Lapsed on the fee recordEnded Aug 30, 2023Medium confidence
US 6,728,897Negotiating takeover in high availability cluster
Formerly held
Term ended
Term ended Dec 26, 2021 · From the USPTO record
Term endedTerm ended Dec 26, 2021From the USPTO record
US 6,333,332Stabilized pharmaceutical compositions containing bupropion hydrochloride
Term ended
Term ended Aug 25, 2020 · From the USPTO record
Term endedTerm ended Aug 25, 2020From the USPTO record
US 6,602,521Multiplex drug delivery system suitable for oral administration
Term ended
Term ended Sep 29, 2018 · From the USPTO record
Term endedTerm ended Sep 29, 2018From the USPTO record
US 7,094,427Combination Immediate Release Controlled Release Levodopa/Carbidopa Dosage Forms
Lapsed on the fee record
Ended Aug 22, 2018 · High confidence
Lapsed on the fee recordEnded Aug 22, 2018High confidence
US 6,730,321Press Coated, Pulsatile Drug Delivery System Suitable for Oral Administration
Term ended
Ended no later than Jun 13, 2018 · Low confidence
Term endedEnded no later than Jun 13, 2018Low confidence
US 6,372,254Press coated, pulsatile drug delivery system suitable for oral administration
Term ended
Term ended Apr 2, 2018 · From the USPTO record
Term endedTerm ended Apr 2, 2018From the USPTO record
US 6,531,158Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
Lapsed on the fee record
Ended Mar 11, 2015 · From the USPTO record
Lapsed on the fee recordEnded Mar 11, 2015From the USPTO record
US 5,885,616Sustained release drug delivery system suitable for oral administration
Term ended
Term ended no later than Mar 23, 2019 · Low confidence
Term endedTerm ended no later than Mar 23, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited